Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Session Icons
Live Streamed
On Demand
Favorite
Facebook
Tweet
Print
Jason Hindman, PharmD, MBA
Gilead Sciences
Disclosure(s): Gilead Sciences, Inc.: Employee, Stocks/Bonds (Private Company)
Poster(s):
(P-386) A Phase 4 Study to Evaluate the Safety and Efficacy of Oral B/F/TAF After Discontinuing Injectable CAB + RPV
Monday, October 20, 2025
12:15 PM - 1:30 PM
US ET